Related Experiment Video
Updated: Feb 10, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
LSD1 negatively regulates autophagy through the mTOR signaling pathway in ovarian cancer cells
Ye Wei1, Tiantian Han1, Ranran Wang1
1School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China.
Abstract:
Lysine-specific demethylase 1 (LSD1) plays a key role in cell proliferation, differentiation and carcinogenesis. In the present study we revealed that LSD1 functioned as an autophagy suppressor in ovarian cancer HO8910 cells. Pharmacological inhibition or genetic knockdown of LSD1 resulted in the elevation of the LC3‑II protein, enhancement of autophagosomal formation and stimulation of the autophagic flux. In addition, knockdown of LSD1 further promoted the serum starvation- and rapamycin-induced autophagy. Furthermore, we demonstrated that LSD1 regulated autophagy via the mTOR signaling pathway. Collectively, our findings identified LSD1 as a novel negative regulator of autophagy through the mTOR signaling pathway in ovarian cancer HO8910 cells and indicated that LSD1 may function as a driving factor of ovarian cancer progression via deregulating autophagy.
Insights
Lysine-specific demethylase 1 (LSD1) suppresses autophagy in ovarian cancer cells. Inhibiting LSD1 boosts autophagy, suggesting it
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Lysine-specific demethylase 1 (LSD1) is implicated in cell proliferation, differentiation, and cancer.
- Autophagy is a cellular degradation process involved in various diseases, including cancer.
Purpose of the Study:
- To investigate the role of LSD1 in regulating autophagy in ovarian cancer.
- To elucidate the molecular mechanisms by which LSD1 affects autophagy in ovarian cancer cells.
Main Methods:
- Ovarian cancer HO8910 cells were used.
- Pharmacological inhibition and genetic knockdown of LSD1 were performed.
- Autophagy markers (LC3-II), autophagosome formation, and autophagic flux were analyzed.
- The mTOR signaling pathway was investigated.
Main Results:
- LSD1 was identified as an autophagy suppressor in ovarian cancer cells.
- Inhibition or knockdown of LSD1 increased LC3-II levels, autophagosome formation, and autophagic flux.
- LSD1 knockdown enhanced autophagy induced by serum starvation and rapamycin.
- LSD1 was found to regulate autophagy via the mTOR signaling pathway.
Conclusions:
- LSD1 is a novel negative regulator of autophagy in ovarian cancer via the mTOR pathway.
- LSD1 may drive ovarian cancer progression by disrupting autophagy.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

